GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™

GEHCV 11.11.2024

Full Press ReleaseSEC FilingsOur GEHCV Tweets

About Gravity Analytica

Recent News

  • 02.13.2025 - GE HealthCare Fourth Quarter and Full Year 2024 Earnings Conference Call
  • 01.15.2025 - University of California San Francisco and GE HealthCare Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology
  • 01.14.2025 - 43rd Annual J.P. Morgan Healthcare Conference

Recent Filings

  • 12.12.2024 - 8-K Current report
  • Collaboration will leverage GE HealthCare’s legacy and scale of imaging innovation and RadNet’s DeepHealth AI-powered clinical and workflow solutions to further the innovation, commercialization, and adoption of AI in imaging.
  • Together,GE HealthCareand RadNet’s DeepHealth aim to create SmartTechnologyTM solutions that harness the power of AI to help redefine radiology workflows and address key challenges across the imaging value chain to improve speed, clinical accuracy, operational efficiency, and elevate patient care.
  • To demonstrate the promise of this strategic relationship, the collaboration will first work to bring together DeepHealth’s AI-powered SmartMammoTM1solution with GE HealthCare’s patient-centric Senographe PristinaTM mammography system to enhance the way women receive breast care.
  • The two companies intend to explore additional areas of collaboration to further expand the access and impact of AI-based workflows in other imaging modalities.

CHICAGO--(BUSINESS WIRE)--Nov. 11, 2024--Today,GE HealthCare(Nasdaq: GEHC) andDeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary ofRadNet, Inc.(Nasdaq: RDNT), announced a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging. Together, the two companies aim to develop SmartTechnologyTM solutions that harness the transformative power of AI to address key challenges across the imaging value chain, including helping increase the efficiency of imaging interpretation and reporting, enabling collaboration across care teams, improving the clinical interpretation of images, and enhancing operational efficiency and productivity. These new SmartTechnology solutions will seek to combine GE HealthCare’s imaging expertise and scale, RadNet’s deep experience in care delivery, and DeepHealth’s AI-powered health informatics portfolio to elevate patient care through improved end-to-end clinical and operational workflows.

With the global cancer burden continuing to rise,2health systems face increasing challenges and seek solutions to enhance early detection and diagnosis when treatment can be most effective. To help address these challenges and demonstrate the promise of this strategic relationship, the two companies will first work to bring together DeepHealth’s AI-basedSmartMammoTM1workflow and clinical solution and GE HealthCare’s patient-centricSenographe PristinaTMmammography system to bring AI-powered clinical imaging support to breast cancer screening.

GE HealthCare’s Senographe Pristina mammography system was designed to ease anxiety the moment the patient enters the exam room. It features an inviting gantry with elegant lighting and rounded shapes, as well as a soft-curved surface that welcomes patients into a space of comfort and support – with 83% of patients rating their experience with Senographe Pristina better and more comfortable than previous exams.3

RadNet’s DeepHealth SmartMammo is an AI-powered SaaS solution designed to seamlessly integrate into existing breast cancer diagnostic workflows, enhancing diagnostic accuracy4and workflow efficiency. By embedding imaging informatics into advanced mammography systems, the solution can support high-volume breast cancer screening programs. The SmartMammo offering will work to prioritize cases based on suspicion level and ensure seamless integration and interoperability with existing healthcare IT infrastructure.

SmartMammo includes: 1) a cloud-native smart enterprise image viewer with PACS functionality that enables fast image loading and real-time data rendering of multimodality images, accessible from any workstation and location, 2) integration with the radiologist worklist and reporting tools to streamline the workflow, and 3) a suite of clinical AI detection tools that offers automatic lesion localization and degree of suspicion that are effective in diverse populations and dense breast tissue.1, 4The cloud-native architecture of the DeepHealth OS powering SmartMammo simplifies support and maintenance while allowing for seamless feature updates and functionality enhancements without any downtime.

Through this collaboration, the two companies also seek to include Smart Alerts, a DeepHealth workflow solution to be integrated with Senographe Pristina that will utilize rapid AI processing with the goal of alerting imaging sites to cases with potentially suspicious lesions in minutes. This kind of solution aims to empower same-day diagnostic exams, follow-up compliance, and reduced anxiety for women with potentially suspicious findings.

"We are thrilled to collaborate withGE HealthCareto accelerate the adoption of AI-powered technologies in radiology," saidKees Wesdorp, President and CEO of RadNet’sDigital Healthdivision. "By combining our pioneering cloud-native operating system, DeepHealth OS, and our AI-powered health informatics portfolio with GE HealthCare’s cutting-edge imaging technology, we are poised to revolutionize large-scale diagnostic and screening programs, streamline radiology workflows, and improve patient outcomes. This collaboration aims to empower healthcare providers with the tools they need to deliver more effective and personalized care at scale."

“GE HealthCare has a legacy of imaging and AI innovation and is committed to our continued pursuit of new technologies that push the boundaries of what is possible to enable precision care. This new collaboration with DeepHealth harnesses our combined strengths to address critical challenges in healthcare today,” explainedRoland Rott, President & Chief Executive Officer of Imaging forGE HealthCare. “As we look to make more personalized, patient-centered breast care a reality – AI continues to show great promise in breast cancer screening from early detection and risk prediction, to reduced callbacks and more efficient workflows for breast imaging providers. We are excited to bring the power of imaging and AI together to elevate personalized breast care for those facing this difficult diagnosis.”

The two companies’ agreement will enableGE Healthcareto distribute SmartMammo and other DeepHealth solutions to imaging providers inthe United Statesas part of GE HealthCare’s comprehensive portfolio of imaging technologies.

In addition to collaborating on SmartMammo,GE HealthCareand RadNet’s DeepHealth intend to explore areas of further collaboration for SmartTechnology solutions in other modalities and clinical domains, to expand the access to and impact of AI-based workflows.

For more information, visit theGE HealthCare(#7330) and DeepHealth (#1340) booths at theRadiological Society of North America2024 Annual Meeting.

AboutGE HealthCare Technologies Inc.GE HealthCareis a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years,GE HealthCareis advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, andPharmaceutical Diagnosticsbusinesses help improve patient care from diagnosis, to therapy, to monitoring. We are a$19.6 billionbusiness with approximately 51,000 colleagues working to create a world where healthcare has no limits. Follow us onLinkedIn,X,Facebook,Instagram, andInsightsfor the latest news, or visit our websitehttps://www.gehealthcare.comfor more information.

AboutRadNet, Inc.RadNet, Inc.is the leading national provider of freestanding, fixed-site diagnostic imaging services inthe United Statesbased on the number of locations and annual imaging revenue.RadNethas a network of 398 owned and/or operated outpatient imaging centers. RadNet’s markets includeArizona,California,Delaware,Florida,Maryland,New Jersey,New YorkandTexas. In addition,RadNetprovides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with affiliated radiologists, and inclusive of full-time and per diem employees and technologists,RadNethas a total of over 10,000 employees. For more information, visithttp://www.radnet.com.

About DeepHealthDeepHealth is a wholly-owned subsidiary ofRadNet, Inc.(NASDAQ: RDNT) and serves as the umbrella brand for all companies withinRadNet'sDigital Healthsegment. DeepHealth provides AI-powered health informatics with the aim of empowering breakthroughs in care through imaging. Building on the strengths of the companies it has integrated and is rebranding (i.e., eRAD Radiology Information and Image Management Systems and Picture Archiving and Communication System, Aidence lung AI, DeepHealth and Kheiron breast AI and Quantib prostate and brain AI), DeepHealth leverages advanced AI for operational efficiency and improved clinical outcomes in lung, breast, prostate, and brain health. At the heart of DeepHealth’s portfolio is a cloud-native operating system - DeepHealth OS - that unifies data across the clinical and operational workflow and personalizes AI-powered workspaces for everyone in the radiology continuum. Thousands of radiologists at hundreds of imaging centers and radiology departments around the world use DeepHealth solutions to enable earlier, more reliable, and more efficient disease detection, including in large-scale cancer screening programs. DeepHealth’s human-centered, intuitive technology aims to push the boundaries of what's possible in healthcare.https://deephealth.com/

Forward Looking StatementThis press release contains “forward-looking statements” within the meaning of the safe harbor provisions of theU.S.Private Securities Litigation Reform Act of 1995. Forward-looking statements, including statements regarding the capabilities ofRadNet,GE Healthcareand DeepHealth’s informatics, hardware and software product portfolios and the collaboration’s impact on radiology practices and healthcare workflow, are expressions of our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods.

Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements.

__________________________

1

Components of SmartMammo are 510(k) pending for use withGE HealthCare.

2

https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services

3

Data on file,GE Healthcare. 83% of patient assessed the exam as more comfortable than previous. IPSOS Patient Satisfaction Study sponsored byGE Healthcare, conducted with 315 patients across 2 sites in Europe.

4

Kim et al. Impact of a Categorical AI System for Digital Breast Tomosynthesis on Breast Cancer Interpretation byBoth General Radiologists and Breast Imaging Specialists. Radiol Artif Intell. 2024. doi: 10.1148/ryai.230137.

View source version onbusinesswire.com:https://www.businesswire.com/news/home/20241111558359/en/

For media inquiries, reach out to:

GE HealthCareEmily NilesGlobal Communications Leader for WHXREmail:emily.niles@gehealthcare.com

DeepHealthAndra AxenteCommunications DirectorPhone: +31 614 440971Email:andra.axente@deephealth.com

RadNet, Inc.Mark StolperExecutive Vice President and Chief Financial Officer310-445-2800

Source:GE HealthCare Technologies Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com